Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-18-013344
Filing Date
2018-03-07
Accepted
2018-03-07 16:03:17
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B3 tv487923_424b3.htm 424B3 2010691
2 GRAPHIC image_001.jpg GRAPHIC 25979
3 GRAPHIC image_002.jpg GRAPHIC 74959
4 GRAPHIC image_003.jpg GRAPHIC 25940
5 GRAPHIC image_004.jpg GRAPHIC 4158
  Complete submission text file 0001144204-18-013344.txt   2192670
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 424B3 | Act: 33 | File No.: 333-208817 | Film No.: 18673365
SIC: 2834 Pharmaceutical Preparations